> News > HAYA amongst the “Top 15 Swiss Biotech Startups Making a Difference in Europe”

HAYA amongst the “Top 15 Swiss Biotech Startups Making a Difference in Europe”

Switzerland has long been known as a booming biotech hotspot in Europe that boasts many high-profile companies. Here are the top 15 biotech companies among the new generation of promising startups in Switzerland.

Last year saw a record-breaking amount of money pouring into the Swiss biotech industry. According to a recent report by the Swiss Biotech Association, biotechs in Switzerland raised approximately €3B (CHF 3.4B), more than doubling 2019’s €1.08B (CHF 1.2B) haul.

Notable Swiss biotech fundraisings included ADC Therapeutics’ €215M IPO on the New York Stock Exchange in May 2020 and CRISPR Therapeutics’ €400M public fundraise the following July.

Switzerland’s success as a bubbling biotech cauldron is reflected in the steadily growing number of biotech companies that have settled there. In the last ten years, the number of biotechs in Switzerland has grown from 236 in 2010 to 314 in 2020. Swiss biotechs employed more than 16,000 people in 2020.

High-profile companies in Switzerland include CRISPR Therapeutics, ADC Therapeutics, AC Immune, Idorsia, and Basilea.

Smaller biotech companies and startups in Switzerland are often spun-out and supported by a number of academic institutions, incubators, and accelerators. Examples include the ETH Zurich, the University of Zurich, the University of Basel, the EPF Lausanne, StartLab, and BaseLaunch.

With helpful tips from local experts, we’ve put together a list of promising biotech startups in Switzerland.

Read the article

Company related to the news